King Hussein Cancer Center

King Hussein Cancer Center (KHCC) is Jordan's leading specialized cancer hospital and one of the most important oncology centers in the Arab world and the broader Middle East. Located on Queen Rania Al-Abdullah Street in Amman and forming part of Al-Hussein Medical City, KHCC was founded in 2003 with a mission to provide world-class cancer care to patients in Jordan and across the region.

KHCC holds JCI (Joint Commission International) accreditation — the international gold standard for hospital quality and patient safety — confirming its commitment to delivering care at internationally recognized standards. The center's bone marrow transplant program holds FACT (Foundation for the Accreditation of Cellular Therapy) accreditation, a specialized certification that recognizes excellence in stem cell transplantation and cellular therapy programs. These dual accreditations make KHCC unique in the region.

KHCC operates as a one-stop destination for cancer care, providing inpatient and outpatient services, surgical oncology, medical oncology, radiation oncology, early detection and screening, intensive care, and psychosocial and rehabilitative support — all under one roof. No time is wasted: diagnosis, staging, and treatment initiation are coordinated to begin as rapidly as possible after a patient's arrival.

The center's philosophy is built on multidisciplinary care, with teams of oncology specialists from different disciplines — medical oncologists, surgeons, radiation oncologists, pathologists, radiologists, and palliative care specialists — meeting regularly to discuss each patient's case and reach consensus treatment decisions. KHCC also recognizes that cancer affects the entire patient and their family, not just their body, and provides comprehensive psychosocial care, social work support, physical therapy, and patient advocacy services alongside medical treatment.

King Hussein Cancer Center offers the full spectrum of adult and pediatric oncology services. Medical oncology provides systemic treatments including chemotherapy, targeted therapy, immunotherapy, and hormone therapy tailored to each patient's cancer type and molecular profile. The medical oncology team is sub-specialized by tumor type, ensuring that each patient is treated by specialists with deep expertise in their specific cancer.

Radiation oncology delivers precision radiotherapy using modern linear accelerators and advanced treatment planning systems for solid tumors across the body. Surgical oncology covers cancer-related surgery across all organ systems including breast, gastrointestinal, gynecological, urological, thoracic, head and neck, and soft tissue malignancies.

The bone marrow transplant (BMT) program holds FACT accreditation and provides both autologous and allogeneic stem cell transplantation for hematological malignancies including leukemia, lymphoma, and multiple myeloma. Pediatric oncology is a dedicated program managing childhood cancers including leukemia, brain tumors, lymphoma, and solid tumors with age-appropriate protocols and family-centered care.

Early detection and cancer screening services are available for patients seeking preventive assessment or routine cancer surveillance. The palliative care and pain management team provides symptom control and quality-of-life support for patients at all stages of their cancer journey. Psycho-social oncology services including psychological counseling, social work support, and patient advocacy programs recognize that effective cancer care extends far beyond medical treatment alone.

King Hussein Cancer Center is purpose-built for comprehensive cancer care, with facilities designed to support diagnosis, treatment, and supportive services within an integrated oncology campus. Inpatient wards provide specialized oncology nursing care, with dedicated areas for BMT patients requiring protective isolation during transplant procedures. Outpatient chemotherapy infusion units allow patients to receive treatment and return home the same day.

The radiation oncology department is equipped with linear accelerators capable of delivering advanced external beam radiotherapy techniques including intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT) for precise tumor targeting while minimizing dose to surrounding healthy tissue.

The surgical suites are fully equipped for oncological surgery across all major organ systems. The bone marrow transplant unit provides sterile, high-dependency care environments required for stem cell transplant patients. The diagnostic pathology laboratory processes tissue biopsies and specimens to provide accurate histological and molecular diagnosis essential for treatment planning.

Imaging services including CT scanning, MRI, PET-CT, ultrasound, and nuclear medicine support staging, treatment planning, and response assessment. The center's multidisciplinary tumor board meeting rooms and conference facilities support the regular case review meetings that underpin KHCC's multidisciplinary care model. Supportive therapy spaces for physiotherapy, occupational therapy, and psychosocial support complete the center's holistic care offering.

King Hussein Cancer Center is the foremost destination for cancer patients from across the Arab world seeking internationally accredited oncology care. Patients travel from Gulf states including Saudi Arabia, Kuwait, UAE, Qatar, and Bahrain, as well as from Iraq, Yemen, Libya, Sudan, Palestinian territories, and other Arab and Islamic countries to receive cancer treatment at KHCC.

KHCC's dual JCI and FACT accreditations, the breadth of its oncology programs, and the depth of subspecialty expertise within its medical team set it apart from cancer centers elsewhere in the region. For patients who cannot access high-quality cancer care in their home countries, or who prefer the quality and affordability of Jordan, KHCC represents a trusted regional option.

Jordan's political stability and Amman's accessibility via Queen Alia International Airport — with direct connections to Gulf airports and other regional cities — make KHCC practical for international patients. The hospital provides services in Arabic and English, with staff experienced in coordinating care for patients and their families from across the Arab and Islamic world. Assistance with appointment scheduling, treatment coordination, and communication with referring physicians is available for international patients.

King Hussein Cancer Center holds JCI (Joint Commission International) accreditation — the internationally recognized gold standard for hospital quality, confirming KHCC's compliance with rigorous global standards for patient safety, clinical care, and hospital governance. JCI accreditation places KHCC among the most credentialed hospitals in the Arab world.

KHCC's bone marrow transplant program holds FACT (Foundation for the Accreditation of Cellular Therapy) accreditation — a specialized certification for stem cell transplantation and cellular therapy programs that is recognized internationally and is extremely rare in the Arab world. FACT accreditation confirms that KHCC's BMT program meets the highest standards for clinical practice, laboratory quality, and patient safety in transplant medicine.

As part of Al-Hussein Medical City, KHCC operates within a broader institutional framework that supports its academic mission. The center pursues continuous quality improvement, evidence-based clinical practice, and active clinical research programs to improve cancer outcomes in Jordan and the region. Its physicians participate in international oncology societies and research networks, ensuring that KHCC's treatment protocols remain aligned with global best practices in cancer medicine.